Abstract cAMP responsive element‐binding protein H (CREBH) is a hepatic transcription factor to be activated during fasting. We generated CREBH knock‐in flox mice, and then generated liver‐specific CREBH transgenic (CREBH L‐Tg) mice in an active form. CREBH L‐Tg mice showed a delay in growth in the postnatal stage. Plasma growth hormone (GH) levels were significantly increased in CREBH L‐Tg mice, but plasma insulin‐like growth factor 1 (IGF1) levels were significantly decreased, indicating GH resistance. In addition, CREBH overexpression significantly increased hepatic mRNA and plasma levels of FGF21, which is thought to be as one of the causes of growth delay. However, the additional ablation of FGF21 in CREBH L‐Tg mice could not correct GH resistance at all. CREBH L‐Tg mice sustained GH receptor (GHR) reduction and the increase of IGF binding protein 1 (IGFBP1) in the liver regardless of FGF21. As GHR is a first step in GH signaling, the reduction of GHR leads to impairment of GH signaling. These data suggest that CREBH negatively regulates growth in the postnatal growth stage via various pathways as an abundant energy response by antagonizing GH signaling.